Windlas Biotech Limited (BOM:543329)
India · Delayed Price · Currency is INR 816.55
+8.30 (1.03%)
At close: Jun 19, 2026
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 16.84 billion as of June 18, 2026. Its market cap has decreased by -11.69% in one year.
Market Cap
16.84B
Enterprise Value
14.49B
Revenue
9.04B
Ranking
n/a
PE Ratio
25.34
Stock Price
816.55
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 16.84B, an increase of 89.77%. That is a compound annual growth rate of 14.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 16.84B | 1.05% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Morepen Laboratories | 28.23B |
| Kwality Pharmaceuticals | 24.50B |
| Venus Remedies | 23.61B |
| Hikal | 23.44B |
| Amrutanjan Health Care | 15.51B |
| Fredun Pharmaceuticals | 13.96B |
| Shukra Pharmaceuticals | 13.71B |
| Syncom Formulations (India) | 13.47B |